Prajna Anirvan (P Anirvan)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Topics

Venous Thromboembolism

Health Insurance

Top Venues

Hepatology international

Journal of gastroenterology and hepatology

Hepatology (Baltimore, Md.)

Journal of Korean medical science

This page only lists publications with an associated author ORCID identifier.

Publications

Prajna Anirvan, Manas Kumar Panigrahi, Shivaram Prasad Singh
Fecal microbiota transplantation in alcoholic hepatitis: new treatment paradigm or a shot in the dark? Hepatology international (2023)
Prajna Anirvan
Portal vein thrombosis in cirrhosis: exploring the uncharted waters. Journal of gastroenterology and hepatology (2023)
Prajna Anirvan, Manas Kumar Panigrahi, Shivaram Prasad Singh
Fecal microbiota transplantation in alcoholic hepatitis: new treatment paradigm or a shot in the dark? Hepatology international (2023)
Prajna Anirvan, Manas Kumar Panigrahi, Shivaram Prasad Singh
Fecal microbiota transplantation in alcoholic hepatitis: new treatment paradigm or a shot in the dark? Hepatology international (2023)
Manas Kumar Panigrahi, Prajna Anirvan
Letter to the editor: Using angiotensin-converting enzyme inhibitors to prevent liver-related events in NAFLD-Revisiting the renin-angiotensin-aldosterone system pathways. Hepatology (Baltimore, Md.) 76 (2) (2022)
Sakir Ahmed, Prajna Anirvan
Top Central Asian Educational Institutions on Publons: Analysis of Researchers and Reviewers. Journal of Korean medical science 36 (21) (2021)
Shivaram Prasad Singh, Prajna Anirvan, Reshu Khandelwal, Sanjaya Kumar Satapathy
Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille? Journal of clinical and translational hepatology 9 (6) (2021)
Sakir Ahmed, Prajna Anirvan
Reply to Rheumatologists' perspective on coronavirus disease 19: is heparin the dark horse for COVID-19? Clinical rheumatology 39 (7) (2020)
Sakir Ahmed, Prajna Anirvan
Targeting the immunology of coronavirus disease-19: synchronization creates symphony. Rheumatology international 40 (8) (2020)